FDA cuts back on U.S. inspections due to COVID-19

By AuntMinnie.com staff writers

March 19, 2020 -- In response to the COVID-19 outbreak, the U.S. Food and Drug Administration (FDA) on March 18 announced that it was suspending all routine surveillance facility inspections in the U.S.

The FDA said it was making the move out of concern for the safety and well-being of its staff, as well as due to industry concerns about visitors to their facilities. The move applies to inspections that the agency conducts every few years based on a risk analysis, the FDA said.

"Importantly, all domestic for-cause inspection assignments will be evaluated and will proceed if mission-critical," said FDA Commissioner Dr. Stephen Hahn in a press statement.

The agency's announcement follows a similar announcement earlier in March, when it suspended inspections at international facilities through the end of April.

Copyright © 2020 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking